Mesothelioma Clinical Trial Tests New Immunotherapy Treatment

An exciting new mesothelioma clinical trial was just announced by the National Cancer Institute. The trial, which starts November 3, 2017 and runs for three years, will test a combination of traditional mesothelioma treatments and mesothelioma immunotherapy. This mesothelioma clinical trial is exciting for two reasons. First, it will test atezolizumab (sold under the brand […]

New Mesothelioma Diagnosis Through Breath Analysis Test

Mesothelioma diagnosis as it stands today is only possible very late in the development of this illness. The inability to detect mesothelioma earlier is part of what makes mesothelioma such a devastating diagnosis. Because it can take decades for mesothelioma symptoms to emerge, by the time a mesothelioma diagnosis is made, it has often progressed […]

Protein Key to Mesothelioma Prognosis

The ability to pinpoint mesothelioma may soon become more accurate, thanks to groundbreaking new research.  If you have received a mesothelioma diagnosis confirming that you in fact have this fierce disease, you may wonder why a detailed precise mesothelioma prognosis matters. Why an Accurate Mesothelioma Diagnosis Matters A more accurate mesothelioma prognosis matters because it […]

New Mesothelioma Clinical Trial Combines Keytruda, CRS-207

Any new mesothelioma clinical trial is worth getting excited about.  The thorough formalized research process involved in a clinical trial offers the best hope we have of vanquishing mesothelioma; the deadly cancer caused by asbestos exposure. A mesothelioma clinical trial offers the opportunity for the medical community to discover new treatments, analyze new data, and […]

Major New Mesothelioma Technology Brought to UCSF

Over the years our sponsor, Kazan Law, has built philanthropic relationships with mesothelioma clients to help fund mesothelioma research and new mesothelioma technology. One such example is mesothelioma victim Gordon Bankhead and his wife, Emily, who wanted to give back and do more for future generations of asbestos victims. As a result of Kazan Law’s […]

Kazan Law Funds University of California, San Francisco Mesothelioma Research

Our mesothelioma law firm’s charitable foundation, the Kazan McClain Partners’ Foundation, has partnered with and donated more than $20 million in grant monies to community, health, and civic organizations. One of our foundation’s most collaborative partners is the University of California, San Francisco (UCSF), a world renowned cancer research institution and the top public recipient […]

The Clemmons Family

Randy and Debbie Clemmons and their sons Brady and Garrett lived just across the bay from San Francisco. They had been married 24 years when Randy was diagnosed with mesothelioma. He had just turned 51. Randy was the morning drive host at a Christian radio station, a dream job he pursued as his second career. […]

Kazan Law’s Tradition of Funding Mesothelioma Research

Mesothelioma Circle’s sponsor, Kazan, McClain, Satterley & Greenwood, has been a pioneering force in asbestos litigation since 1974. The firm’s charitable foundation, the Kazan McClain Partners’ Foundation, formed in 1994, has pledged their serious and substantial commitment to giving back by donating more than $20 million in grant monies to community, health, and civic organizations. […]

Mesothelioma Prevention Through Firefighter Cancer Registry

Mesothelioma prevention typically is thought to be impossible. Most people do not realize that they are being exposed to asbestos, the only known cause of mesothelioma, when it occurs.  The mesothelioma facts are that asbestos particles released into the air as asbestos dust can easily be inhaled without any indication that this is what is […]

Nivolumab Mesothelioma Clinical Trials Search for Answers

Mesothelioma clinical trials can sometimes offer a silver lining to the dark cloud of mesothelioma confronting patients and their families. If you can volunteer to be a participant in a mesothelioma clinical trial, you might get to road test a new effective mesothelioma treatment not on the market yet. Or if you or your doctor […]